Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · Real-Time Price · USD
61.34
-1.96 (-3.10%)
At close: Aug 20, 2026, 4:00 PM EDT
61.61
+0.27 (0.44%)
Pre-market: Aug 21, 2026, 7:16 AM EDT

Vaxcyte Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-1,064-766.63-463.93-402.27-223.49-100.08
Depreciation & Amortization
26.7824.8615.8510.179.453.46
Loss (Gain) From Sale of Assets
-----0.1
Loss (Gain) From Sale of Investments
-9.32-14.43-38.7-34.78-0.951.41
Stock-Based Compensation
150.51138.8584.8248.7623.6510.73
Other Operating Activities
4.93-34.774.23-8-
Change in Accounts Payable
70.8319.9134.5811.232.9-12.47
Change in Other Net Operating Assets
-60.69-23.36-89.4870.19.84-24.54
Operating Cash Flow
-881.23-655.58-452.63-296.79-170.6-121.39
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-39.84-56.97-119.16-67.88-5.84-6.56
Sale of Property, Plant & Equipment
-----0.03
Investment in Securities
190.44494.33-1,887-705.4380.43-205.78
Investing Cash Flow
150.6437.35-2,006-773.3174.59-212.31

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Issuance of Common Stock
622.3613.012,463643.69862.4117.8
Repurchase of Common Stock
-16.34-10.99-14.29-3.88-0.86-
Financing Cash Flow
606.022.012,449639.81861.5517.8

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
1.22.440.43-6.690.14-0.44
Net Cash Flow
-123.41-213.77-9.36-436.97765.67-316.34

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-921.07-712.55-571.79-364.67-176.44-127.95
Free Cash Flow Growth
------
Free Cash Flow Per Share
-6.62-5.24-4.69-3.75-2.72-2.46
Levered Free Cash Flow
-485.76-430.85-403.44-202.41-107.53-88.16
Unlevered Free Cash Flow
-485.76-430.85-403.44-202.41-107.52-88.16

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
-----0.01
Change in Working Capital
10.14-3.45-54.981.3212.74-37.01
SEC Filings: 10-K · 10-Q